Use of multikinase inhibitor
AssigneeTransthera Sciences (Nanjing), Inc.
InventorsPeng Peng, Xiaoyan Qiang, Frank Wu
Life of this patent
Estimating the term…
Loading patent…
AssigneeTransthera Sciences (Nanjing), Inc.
InventorsPeng Peng, Xiaoyan Qiang, Frank Wu
Estimating the term…
The present invention belongs to the technical field of medicines, relates to novel use of a multi-kinase inhibitor, and particularly relates to a compound of general formula (I) or a pharmaceutically acceptable salt, a stereoisomer and a crystal form thereof for use in the treatment of biliary tract cancer, a pharmaceutical composition comprising the compound, a method for treating biliary tract cancer by using the compound, use of the compound in the treatment of biliary tract cancer, and use of the compound in the preparation of a medicament for treating biliary tract cancer. The variables in the general formula are defined in the specification. Research shows that the multi-kinase inhibitor compound of general formula (I) or the pharmaceutically acceptable salt, the stereoisomer and the crystal form thereof have a treatment effect on biliary tract cancer, and especially on cholangiocarcinoma, so that the compound of the present invention has huge clinical application potential.
A method of treating a patient suffering from biliary tract cancer;
Dependencies are inferred from the claim text.